These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11847948)

  • 1. Alteplase use for prevention of central line occlusion in a preterm infant.
    Lee EK
    Ann Pharmacother; 2002 Feb; 36(2):272-4. PubMed ID: 11847948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices.
    Timoney JP; Malkin MG; Leone DM; Groeger JS; Heaney ML; Keefe DL; Klang M; Lucarelli CD; Muller RJ; Eng SL; Connor M; Small TN; Brown AE; Saltz LB
    J Clin Oncol; 2002 Apr; 20(7):1918-22. PubMed ID: 11919252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients.
    Shen V; Li X; Murdock M; Resnansky L; McCluskey ER; Semba CP;
    J Pediatr Hematol Oncol; 2003 Jan; 25(1):38-45. PubMed ID: 12544772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).
    Blaney M; Shen V; Kerner JA; Jacobs BR; Gray S; Armfield J; Semba CP;
    J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1745-51. PubMed ID: 17142704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
    Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
    J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteplase versus urokinase for occluded hemodialysis catheters.
    Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
    Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator to restore catheter patency: efficacy and safety analysis from a multihospital NICU system.
    Scott DM; Ling CY; MacQueen BC; Baer VL; Gerday E; Christensen RD
    J Perinatol; 2017 Mar; 37(3):291-295. PubMed ID: 27831547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
    Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
    Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteplase for the treatment of catheter occlusion in pediatric patients.
    Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
    Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteplase infusion versus dwell for clearance of partially occluded central venous catheters in critically ill pediatric patients.
    Ragsdale CE; Oliver MR; Thompson AJ; Evans MC
    Pediatr Crit Care Med; 2014 Jul; 15(6):e253-60. PubMed ID: 24751787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.
    Semba CP; Deitcher SR; Li X; Resnansky L; Tu T; McCluskey ER;
    J Vasc Interv Radiol; 2002 Dec; 13(12):1199-205. PubMed ID: 12471182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer.
    Terrill KR; Lemons RS; Goldsby RE
    J Pediatr Hematol Oncol; 2003 Nov; 25(11):864-7. PubMed ID: 14608195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial.
    Gittins NS; Hunter-Blair YL; Matthews JN; Coulthard MG
    Arch Dis Child; 2007 Jun; 92(6):499-501. PubMed ID: 17068072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of catheter occlusion in pediatric patients.
    Kerner JA; Garcia-Careaga MG; Fisher AA; Poole RL
    JPEN J Parenter Enteral Nutr; 2006; 30(1 Suppl):S73-81. PubMed ID: 16387916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients.
    Ng R; Li X; Tu T; Semba CP
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):45-9. PubMed ID: 14709686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteplase use for malfunctioning central venous catheters correlates with catheter-associated bloodstream infections.
    Rowan CM; Miller KE; Beardsley AL; Ahmed SS; Rojas LA; Hedlund TL; Speicher RH; Nitu ME
    Pediatr Crit Care Med; 2013 Mar; 14(3):306-9. PubMed ID: 23392362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
    Little MA; Walshe JJ
    Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices.
    Davis SN; Vermeulen L; Banton J; Schwartz BS; Williams EC
    Am J Health Syst Pharm; 2000 Jun; 57(11):1039-45. PubMed ID: 10876745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study.
    Choi M; Massicotte MP; Marzinotto V; Chan AK; Holmes JL; Andrew M
    J Pediatr; 2001 Jul; 139(1):152-6. PubMed ID: 11445811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.